Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman [NA]
This is a clinical trial update describing the MED-AD smartphone app intended to improve medication adherence in patients with cardiovascula…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Intervention Study on Digital Health Management [NA]
A digital health management intervention trial sponsored by Shanghai 10th People's Hospital is listed as not yet recruiting and targets hype…
-
FDA approval · 2025-04-22FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Colesevelam hydrochloride (generic) submitted by Bionpharma Inc., effectively granting approval …
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit
A completed clinical trial (NCT06334042) assessed how chromium levels influence glucose and lipid metabolism as well as morbidity and mortal…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering [Phase 4]
Phase 4 clinical trial updating LDL-C optimization with inclisiran for patients in whom drug-drug interactions limit LDL lowering; currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-10FDA Approved: NIACIN — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA has approved a supplemental application for NIACIN submitted by Macleods Pharmaceuticals Limited.
-
FDA approval · 2025-04-10FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS)
The FDA approved a supplemental application for rosuvastatin calcium from Puracap Laboratories LLC dba Blu Pharmaceuticals, granting approva…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053 [Phase 1]
A Phase 1 single ascending dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of SYH2053 has been complet…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels [NA]
A completed clinical trial evaluated the effects of different rosuvastatin doses on LDL cholesterol and liver/muscle safety markers (AST and…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Project WHADE: A Partner-Based Physical Activity Program for Women [NA]
Rowan University reports completion of Project WHADE, a partner-based physical activity program for women. The program targets hypertension …
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications [NA]
A completed clinical trial assessed whether personalized patient data and behavioral nudges improve adherence to chronic cardiovascular medi…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Preventative Screening and Health Coaching in a Food Insecure Population [NA]
A clinical trial update describes a study on preventative screening and health coaching aimed at reducing cardiovascular and cardiometabolic…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients [NA]
A completed clinical study evaluated the effect of genistein on restructuring gut microbiota in patients with hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C [Phase 1]
Phase 1 study in Chinese participants with elevated LDL-C evaluated pharmacokinetics, pharmacodynamics, safety and tolerability of Inclisira…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
ClinicalTrials.gov update indicates a study evaluating the efficacy of adding probucol to statin therapy for ischemic stroke is currently in…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Nigella Sativa Supplementation in Hyperlipidemia Treatment [NA]
A completed clinical trial evaluated Nigella Sativa supplementation for hyperlipidemia.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Observation on the Correlation Between Serum/Fecal Isoflavones, Abundance of TMA-producing Bacteria and Serum TMAO in Hyperlipidemia and Healthy Subjects
A recruiting observational study from Zhujiang Hospital investigating the correlation between serum and fecal isoflavones, TMA-producing gut…
-
FDA approval · 2025-03-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium by Aurobindo Pharma Limited.
-
FDA approval · 2025-03-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for pravastatin sodium from Cipla USA Inc., authorizing changes to the existing generic product.
-
FDA approval · 2025-03-17FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for pravastatin sodium, a generic statin, approving changes to the product's la…
-
FDA approval · 2025-03-17FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for pravastatin sodium from Accord Healthcare Inc., supporting continued regulatory approval for thi…
-
FDA approval · 2025-03-13FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for atorvastatin calcium filed by Novadoz Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI [Phase 4]
Phase 4 trial evaluating early initiation of evolocumab on lipid profiles in patients with acute coronary syndrome undergoing percutaneous c…
-
FDA approval · 2025-03-12FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for rosuvastatin (generic rosuvastatin), authorizing its marketing in the Unit…
-
FDA approval · 2025-03-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for atorvastatin calcium, expanding the availability of a generic statin product.